Clinical Trials in France, Lyon
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Efficacy and Safety of Dalbavancin As Suppressive Therapy
Efficacy and Safety of DalbavancinIn Subjects Who Received SAT with DALFor Acute or Chronic Infections Between July 2019 and December 2024
Hospices Civils de Lyon33 enrolled1 locationNCT06899906
Recruiting
Comparing Montiroing Cardiac Index by Transpulmonary Thermodilution and Transesophageal Echocardiography During Liver Transplantation
Liver Transplantation
Hospices Civils de Lyon30 enrolled1 locationNCT06899867